IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% ...
Northeastern Global News

These Northeastern researchers are helping move cognitive tests from the clinic to the home.

An at-home cognitive test to measure brain function produced reliable results in a new study, Northeastern psychology researchers report.

Dear Doctor: Which prostate test should I trust when the results tell different stories?

I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about ...
kantesti.net

Chronic Fatigue Syndrome Diagnosis: Criteria and Next Steps

Friendly ME/CFS is diagnosed from a characteristic symptom pattern and reduced function—not a positive blood test. The ...

13 Changes Leaders Must Make To Shift From Hours To Outcomes

Employees need autonomy over execution, supported by human-centered leadership, mutual trust and accountability for both ...